Head-To-Head Contrast: Viemed Healthcare (NASDAQ:VMD) and BioLife Solutions (NASDAQ:BLFS)

BioLife Solutions (NASDAQ:BLFS) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for BioLife Solutions and Viemed Healthcare, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1	0	3	1	2.80
Viemed Healthcare	0	2	0	0	2.00

BioLife Solutions presently has a consensus target price of $32.00, suggesting a potential upside of 38.41%. Given BioLife Solutions’ stronger consensus rating and higher possible upside, research analysts plainly believe BioLife Solutions is more favorable than Viemed Healthcare.

Institutional and Insider Ownership

93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares BioLife Solutions and Viemed Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-4.50%	1.71%	1.54%
Viemed Healthcare	5.20%	10.52%	7.60%

Valuation and Earnings

This table compares BioLife Solutions and Viemed Healthcare”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$96.21 million	11.75	-$4.59 million	($0.11)	-210.18
Viemed Healthcare	$270.28 million	1.31	$14.93 million	$0.37	24.89

Viemed Healthcare has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

BioLife Solutions has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.

Summary

Viemed Healthcare beats BioLife Solutions on 8 of the 15 factors compared between the two stocks.

About BioLife Solutions

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

About Viemed Healthcare

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.